An experimental Roche drug reduced levels of urine proteins indicative of disease in a Phase 3 clinical trial, results that could position the therapy to join an increasingly competitive market of ...

Pelago launched a behavioral health platform that integrates substance use, mental health and behavioral addiction care, ...

This month, Bayesian Health became the first company to receive FDA clearance for an AI-powered continuous monitoring system for sepsis. Many AI tools for sepsis detection have historically operated ...

Healthcare leaders know how to test software. We don't yet have a shared playbook for onboarding agents expected to do a job ...

Amgen’s dazodalibep led to statistically significant and clinically meaningful results, according to preliminary Phase 3 ...

Hospitals' operating margins fell to 1.4% in July, down from 2.2% in May and June, according to new data from Kaufman Hall.

Novartis is acquiring a Sironax platform technology designed to transport a range of drug modalities across the protective ...

Inspiren, a company selling an AI-powered senior living platform, raised $70 million in Series C funding led by NewView ...

The next evolution in ADHD therapy needs to focus not only on drug efficacy but also on how treatment aligns with the ...

The Series C funding round was from The General Partnership, Index Ventures, General Catalyst and Andreessen Horowitz.

HHS Secretary Robert F. Kennedy Jr. named eight new members to the U.S. Preventive Services Task Force this week, completing ...

As Medicare Advantage denial rates climb, health systems are dropping plans and steering patients back to traditional ...